Date post: | 26-Feb-2018 |
Category: |
Documents |
Upload: | taufik-tias |
View: | 225 times |
Download: | 0 times |
of 22
7/25/2019 TB Fulltext
1/22
Background
Tuberculosis (TB), a multisystemic disease with myriad presentations and manifestations, is
the most common cause of infectious diseaserelated mortality worldwide. The World Health
Organiation (WHO) has estimated that ! billion people ha"e latent TB and that globally, in!##$, the disease %illed &.' million people.$ (*ee +pidemiology.)
lthough TB rates are decreasing in the -nited *tates, the disease is becoming more common
in many parts of the world. n addition, the pre"alence of drug/resistant TB is also increasing
worldwide. 0oinfection with the human immunodeficiency "irus (H1) has been an
important factor in the emergence and spread of resistance. && (*ee Treatment.)
Mycobacterium tuberculosis, a tubercle bacillus, is the causati"e agent of TB. t belongs to a
group of closely related organisms2includingM africanum,M bovis, andM microti2in the
M tuberculosiscomple3. (*ee +tiology.) n image of the bacterium is seen below.
-nder a high magnification of &445$3, this scanning electron
micrograph depicts some of the ultrastructural details seen in the cell wall configuration of a
number of 6ram/positi"e 7ycobacterium tuberculosis bacteria. s an obligate aerobic
organism, 7. tuberculosis can only sur"i"e in an en"ironment containing o3ygen. Thisbacterium ranges in length between !/5 microns, with a width between #.!/#.4 microns.
mage courtesy of the 0enters for 8isease 0ontrol and 9re"ention:8r. ;ay Butler.
The lungs are the most common site for the de"elopment of TB< =4> of patients with TB
present with pulmonary complaints. +3trapulmonary TB can occur as part of a primary or
late, generalied infection. (*ee 9athophysiology and 9resentation.)
The primary screening method for TB infection (acti"e or latent) is the 7antou3 tuberculin
s%in testwith purified protein deri"ati"e (998). n in "itro blood test based on interferon/
gamma release assay (6;) with antigens specific for 7 tuberculosis can also be used to
screen for latent TB infection. 9atients suspected of ha"ing TB should submit sputum for
acid/fast bacilli (?B) smear and culture. (*ee Wor%up.)
The usual treatment regimen for TB cases from fully susceptible M tuberculosisisolates
consists of @ months of multidrug therapy. +mpiric treatment starts with a 5/drug regimen of
isoniaid, rifampin, pyrainamide, and either ethambutol or streptomycin< this therapy is
subseAuently adusted according to susceptibility testing results and to3icity. 9regnant
women, children, H1/infected patients, and patients infected with drug/resistant strains
reAuire different regimens. (*ee Treatment and 7edication.)
http://www.cdc.gov/tb/education/Mantoux/default.htmhttp://www.cdc.gov/tb/education/Mantoux/default.htmhttp://www.cdc.gov/tb/education/Mantoux/default.htmhttp://www.cdc.gov/tb/education/Mantoux/default.htm7/25/2019 TB Fulltext
2/22
Caws "ary from state to state, but communicable/disease laws typically empower public
health officials to in"estigate suspected cases of TB, including potential contacts of persons
with TB. n addition, patients may be incarcerated for noncompliance with therapy.
Dew TB treatments are being de"eloped,&! and new TB "accines are under in"estigation.
(*ee +pidemiology and Treatment.)
Historical background
TB is an ancient disease. *igns of s%eletal TB (9ott disease) ha"e been found in remains from
+urope from Deolithic times (=### B0+), ancient +gypt (## B0+), and the pre/0olumbian
Dew World. TB was recognied as a contagious disease by the time of Hippocrates (5##
B0+), when it was termed EphthisisE (6ree% fromphthinein, to waste away). n +nglish,
pulmonary TB was long %nown by the term Fconsumption.G 6erman physician ;obert och
disco"ered and isolatedM tuberculosisin &==!.
The worldwide incidence of TB increased with population density and urban de"elopment, sothat by the ndustrial ;e"olution in +urope (&'4#), it was responsible for more than !4> of
adult deaths. n the early !#th century, TB was the leading cause of death in the -nited
*tates< during this period, howe"er, the incidence of TB began to decline because of "arious
factors, including the use of basic infection/control practices (eg, isolation).
Resurgence of TB
The -* 0enters for 8isease 0ontrol and 9re"ention (080) has been recording detailed
epidemiologic information on TB since &$4I. Beginning in &$=4, a resurgence of TB was
noted. The increase was obser"ed primarily in ethnic minorities and especially in personsinfected with H1. TB control programs were re"amped and strengthened across the -nited
*tates, and rates again began to fall. (*ee +pidemiology.)
s an 8* (acAuired immunodeficiency syndrome)related opportunistic infection, TB is
associated with H1 infections, with dual infections being freAuently noted. 6lobally,
coinfection with H1 is highest in *outh frica, ndia, and Digeria. 9ersons with 8* are
!#/5# times more li%ely than immunocompetent persons to de"elop acti"e TB.&I
0orrespondingly, TB is the leading cause of mortality among persons infected with H1.&5
Worldwide, TB is most common in frica, the West 9acific, and +astern +urope. These
regions are plagued with factors that contribute to the spread of TB, including the presence oflimited resources, H1 infection, and multidrug/resistant (78;) TB. (*ee +pidemiology.)
Drug-resistant TB
78;/TB is defined as resistance to isoniaid and rifampin, which are the ! most effecti"e
first/line drugs for TB. n !##@, an international sur"ey found that !#> ofM tuberculosis
isolates were 78;.&5 rare type of 78;/TB, called e3tensi"ely drug/resistant TB (J8;/
TB), is resistant to isoniaid, rifampin, any fluoroAuinolone, and at least one of I inectable
second/line drugs (ie, ami%acin, %anamycin, or capreomycin).$ J8;/TB resistant to all anti/
TB drugs tested has been reported in taly, ran, and ndia.&4
http://emedicine.medscape.com/article/226141-overviewhttp://emedicine.medscape.com/article/226141-overview7/25/2019 TB Fulltext
3/22
7ultiple factors contribute to the drug resistance ofM tuberculosis,including incomplete and
inadeAuate treatment or adherence to treatment, logistical issues, "irulence of the organism,
multidrug transporters, host genetic factors, and H1 infection. study from *outh frica
found high genotypic di"ersity and geographic distribution of J8;/TB isolates, suggesting
that acAuisition of resistance, rather than transmission, accounts for between @I> and '4> of
J8;/TB cases.&@
Statistics
n a !##= report by the WHO, the proportion of TB cases in which the patient was resistant to
at least & antituberculosis drug "aried widely among different regions of the world, ranging
from #> to o"er 4#>< the proportion of 78;/TB cases ranged from #> to o"er !#>. The
WHO calculated that the global population/weighted proportion of 78;/TB was !.$> in
new TB cases, &4.I> in pre"iously treated patients, and 4.I> in all TB cases.&'
n the -nited *tates, the percentage of 78;/TB cases has increased slowly, from #.$> of the
total number of reported TB cases in !##= to &.I> of cases in !#&&. lthough the percentageof -*/born patients with primary 78;/TB has remained below &> since &$$', the
proportion of cases in which the patient was foreign born increased from !4.I> in &$$I to
=!.'> in !#&&.&=
J8;/TB is becoming increasingly significant.&' ccording to the -* Dational TB
*ur"eillance *ystem (DT**), between &$$I and !##@ a total of 5$ cases (I> of e"aluable
78;/TB cases) met the re"ised case definition for J8;/TB. The largest number of J8;/
TB cases was found in Dew Kor% 0ity and 0alifornia.
Cure rate
The cure rate in persons with 78;/TB is 4#/@#>, compared with $4/$'> for persons with
drug/susceptible TB.&5 The estimated cure rate for J8;/TB is I#/4#>.$ n people who are
also infected with H1, 78;/TB and J8;/TB often produce fulminant and fatal disease in e3posed health/care wor%ers.
Global surveillance and treatment of TB
s pre"iously stated, multidrug resistance has been dri"en by poor compliance with TB
therapies,resulting in difficulties in controlling the disease. 0onseAuently, a threat of globalpandemic occurred in the late &$=#s and early &$$#s. ;eacting to these signals, the WHO
de"eloped a plan to try to identify '#> of the worldLs cases of TB and to completely treat at
least =4> of these cases by the year !###.
Out of these goals were born maor TB sur"eillance programs and the concept of directly
obser"ed therapy (8OT), which reAuires a third party to witness compliance with
pharmacotherapy. With worldwide efforts, global detection of smear/positi"e cases rose from
&&> (&$$&) to 54> (!##I), with '&/=$> of those cases undergoing complete treatment.
Approach to TB in the emergency department
7/25/2019 TB Fulltext
4/22
8espite the importance of early isolation of patients with acti"e TB, a standardied triage
protocol with acceptable sensiti"ities has yet to be de"eloped.&$ 7oran et al demonstrated
that among patients with acti"e TB in the emergency department (+8), TB was often
unsuspected, and isolation measures were not used.!# The difficulty in establishing such a
protocol only highlights the importance of the emergency physicianMs role in the prompt
identification and isolation of acti"e TB.
large percentage of +8 patients are at increased ris% for ha"ing acti"e TB, including
homeless:shelter/dwelling patients, tra"elers from endemic areas, immunocompromised
patients, health/care wor%ers, and incarcerated patients. Therefore, emergency physicians
must consider the management and treatment of TB as a critical public health measure in the
pre"ention of a new epidemic.!&
?or high/ris% cases, prehospital wor%ers can assist in identifying household contacts who may
also be infected or who may be at high ris% of becoming infected.
9rehospital wor%ers should be aware that any case of acti"e TB in a young child indicatesdisease in & or more adults with close contact, usually within the same household. TB in a
child is a sentinel e"ent indicating recent transmission.
Etrapulmonary involvement in TB
+3trapulmonary in"ol"ement occurs in one fifth of all TB cases< @#> of patients with
e3trapulmonary manifestations of TB ha"e no e"idence of pulmonary infection on chest
radiographs or in sputum cultures.
!utaneous TB
The incidence of cutaneous TB appears low. n areas such as ndia or 0hina, where TB
pre"alence is high, cutaneous manifestations of TB (o"ert infection or the presence of
tuberculids) ha"e been found in less than #.&> of indi"iduals seen in dermatology clinics.
"cular TB
TB can affect any structure in the eye and typically presents as a granulomatous process.
eratitis, iridocyclitis, intermediate u"eitis, retinitis, scleritis, and orbital abscess are within
the spectrum of ocular disease. 0horoidal tubercles and choroiditis are the most common
ocular presentations of TB. dne3al or orbital disease may be seen with preauricularlymphadenopathy. Because of the wide "ariability in the disease process, presenting
complaints will "ary.
7ost often, patients will complain of blurry "ision that may or may not be associated with
pain and red eye. n the rare case of orbital disease, proptosis, double "ision, or e3traocular
muscle motility restriction may be the presenting complaint. 9reseptal cellulitis in children
with spontaneous draining fistula may also occur. n cases of both pulmonary and
e3trapulmonary TB, there may be ocular findings without ocular complaints.
n patients with confirmed acti"e pulmonary or acti"e, nonocular e3trapulmonary TB, ocular
incidence ranges from &.5/4.'5>. n H1 patients, the incidence of ocular TB may be higher,with a reported pre"alence of from !.=/&&.5>.
7/25/2019 TB Fulltext
5/22
#atient education
9atient information on TB can be found at the following sitesN
080 Tuberculosis (TB)
World Health Organiation Tuberculosis
?or patient education information, see thenfections 0enter, as well as Tuberculosis.
#athophysiology
nfection withM tuberculosisresults most commonly through e3posure of the lungs or
mucous membranes to infected aerosols. 8roplets in these aerosols are &/4 m in diameter< in
a person with acti"e pulmonary TB, a single cough can generate I### infecti"e droplets, with
as few as bacilli needed to initiate infection.
When inhaled, droplet nuclei are deposited within the terminal airspaces of the lung. The
organisms grow for !/&! wee%s, until they reach ##/,### in number, which is sufficient
to elicit a cellular immune response that can be detected by a reaction to the tuberculin s%in
test.
7ycobacteria are highly antigenic, and they promote a "igorous, nonspecific immune
response. Their antigenicity is due to multiple cell wall constituents, including glycoproteins,
phospholipids, and wa3 8, which acti"ate Cangerhans cells, lymphocytes, and
polymorphonuclear leu%ocytes
When a person is infected withM tuberculosis, the infection can ta%e & of a "ariety of paths,
most of which do not lead to actual TB. The infection may be cleared by the host immune
system or suppressed into an inacti"e form called latent tuberculosis infection (CTB), with
resistant hosts controlling mycobacterial growth at distant foci before the de"elopment of
acti"e disease. 9atients with CTB cannot spread TB.
The lungs are the most common site for the de"elopment of TB< =4> of patients with TB
present with pulmonary complaints. +3trapulmonary TB can occur as part of a primary or
late, generalied infection. n e3trapulmonary location may also ser"e as a reacti"ation site),
followed by Hispanics (!$>) and non/Hispanic blac%s:frican mericans (&4>). Howe"er,
blac%s:frican mericans represented I$> of TB cases in -*/born persons.&=
There were 4!$ deaths from TB in !##$, the most recent year for which these data are
a"ailable.
&nternational statistics
6lobally, more than & in I indi"iduals is infected with TB.I= ccording to the WHO, there
were =.= million incident cases of TB worldwide in !#, with &.& million deaths from TB
among H1/negati"e persons and an additional #.I4 million deaths from H1/associated TB.
n !##$, almost million children were orphaned as a result of parental deaths caused by
TB.I$
O"erall, the WHO noted the followingI$ N
The absolute number of TB cases has been falling since !##@ (rather than rising
slowly, as indicated in pre"ious global reports)
TB incidence rates ha"e been falling since !##! (! years earlier than pre"iously
suggested)
+stimates of the number of deaths from TB each year ha"e been re"ised downwards
The 4 countries with the highest number of incident cases in !# were ndia, 0hina, *outh
frica, ndonesia, and 9a%istan. ndia alone accounted for an estimated !@> of all TB cases
worldwide, and 0hina and ndia together accounted for I=>.I$
Race-related demographics
n !#&&, only &@> of TB cases in the -* occurred in non/Hispanic whites< =5> occurred in
racial and ethnic minorities, as follows&= N
Hispanics / !$>
sians / I#>
Don/Hispanic blac%s:frican mericans / !I>
7/25/2019 TB Fulltext
13/22
merican ndians:nati"e las%ans / &>
Dati"e Hawaiians:other 9acific slanders &>
Howe"er, race is not clearly an independent ris% factor, as foreign/born persons account for
''> of TB cases among Hispanics and $@> of TB cases among sians, but only !$> of TBcases among blac%s. This s%ewed distribution is most li%ely due to socioeconomic factors.
%e-related demographics
8espite the fact that TB rates ha"e declined in both se3es in the -nited *tates, certain
differences e3ist. TB rates in women ha"e declined with age, but in men, rates ha"e increased
with age. n addition, men are more li%ely than women to ha"e a positi"e tuberculin s%in test
result. The reason for these differences may be social, rather than biologic, in nature.
The estimated se3 pre"alence for TB "aries by source, from no se3 pre"alence to a male/to/female ratio in the -nited *tates of !N&.
Age-related demographics
Higher rates of TB infection are seen in young, nonwhite adults (pea% incidence, !4/5# y)
than in white adults. n addition, white adults manifest the disease later (pea% incidence, age
'# y) than do nonwhite persons.
n the -nited *tates, more than @#> of TB cases occur in persons aged !4/@5 years< howe"er,
the age/specific ris% is highest in persons older than @4 years. I$ TB is uncommon in children
aged 4/&4 years.
#rognosis
?ull resolution is generally e3pected with few complications in cases of non/78;/ and non/
J8;/TB, when the drug regimen is completed. mong published studies in"ol"ing 8OT
treatment of TB, the rate of recurrence ranges from #/&5>. 5# n countries with low TB rates,
recurrences usually occur within &! months of treatment completion and are due to relapse. 5&
n countries with higher TB rates, most recurrences after appropriate treatment are probably
due to reinfection rather than relapse.5!
9oor prognostic mar%ers include e3trapulmonary in"ol"ement, an immunocompromisedstate, older age, and a history of pre"ious treatment. n a prospecti"e study of &$$ patients
with TB in 7alawi, &! (@>) died. ;is% factors for dying were reduced baseline TD?/P
response to stimulation (with heat/%illedM tuberculosis), low body mass inde3, and ele"ated
respiratory rate at TB diagnosis.5I
7/25/2019 TB Fulltext
14/22
This radiograph shows a patient with typical radiographic fndings otuberculosis.
This is a chest radiograph taken ater therapy was administered to a patient withtuberculosis.
7/25/2019 TB Fulltext
15/22
This posteroanterior chest radiograph shows right upper lobe consolidation withminimal volume loss (elevated horizontal fssure) and a cavity in a 43yearoldman who presented with cough and ever.
;eferences
&. yie%o S, buogi C, *imchowit B, Bu%usi +, *mith H, ;eingold . +fficacy of
isoniaid prophylactic therapy in pre"ention of tuberculosis in childrenN a meta/
analysis.(MC "nfect %is. ?eb !# !#&5
7/25/2019 TB Fulltext
16/22
&!. Best +"idence Burman WS, 6oldberg *, Sohnson SC, 7uanye 6, +ngle 7, 7osher
W, et al. 7o3iflo3acin "ersus ethambutol in the first ! months of treatment for
pulmonary tuberculosis.Am * Respir Crit Care Med. ug & !##@
7edline.
!!. 1erhagen C7, "an den Hof *, "an 8eute%om H, Hermans 9W, remer , Borgdorff
7W, et al. 7ycobacterial factors rele"ant for transmission of tuberculosis.* "nfect
%is. 7ay !#&&
!I. Ceung 00, Cam TH, 0han W7, Kew WW, Ho *, Ceung 6, et al. Cower ris% of
tuberculosis in obesity.Arch "ntern Med. Sun !4 !##'
7/25/2019 TB Fulltext
17/22
!5. *lama , 0hiang 0K, +narson 8, Hassmiller , ?anning , 6upta 9, et al. Tobacco
and tuberculosisN a Aualitati"e systematic re"iew and meta/analysis."nt * Tuberc .ung
%is. Oct !##'
7/25/2019 TB Fulltext
18/22
I@. hor 00, 0hapman *S, 1annberg ?O, 8unne , 7urphy 0, Cing +K, et al. 7al
functional "ariant is associated with protection against in"asi"e pneumococcal
disease, bacteremia, malaria and tuberculosis.Nat $enet. pr !##'
5'. *onnenberg 9, 6lynn S;, ?ielding , 7urray S, 6odfrey/?aussett 9, *hearer *. How
soon after infection with H1 does the ris% of tuberculosis start to increase
retrospecti"e cohort study in *outh frican gold miners.* "nfect %is. San &4
!##4
7/25/2019 TB Fulltext
19/22
5=. 7uga ;, ?erreros , Cangohr , de Olalla 96, 8el ;omero S, Yuintana 7, et al.
0hanges in the incidence of tuberculosis in a cohort of H1/serocon"erters before and
after the introduction of H;T.A"%S. Do" I# !##'
4&. 6uideline Sensen 9, Cambert C, ademarco 7?, ;idon ;. 6uidelines for
pre"enting the transmission of 7ycobacterium tuberculosis in health/care settings,
!##4.MM)R Recomm Rep. 8ec I# !##4
7/25/2019 TB Fulltext
20/22
4$. Bada% ?Z, is%a 8C, *etterAuist *, Hartley 0, OL0onnell 7, Hopfer ;C.
0omparison of mycobacteria growth indicator tube with B0T+0 5@# for detection
and reco"ery of mycobacteria from clinical specimens.* Clin Microbiol. *ep
&$$@
7/25/2019 TB Fulltext
21/22
acti"e tuberculosisN an update.Am * Respir Crit Care Med. San & !#&&
7/25/2019 TB Fulltext
22/22
=!. Weir ;+, 6ora%/*tolins%a 9, ?loyd *, Calor 7, *tenson *, Branson , et al.
9ersistence of the immune response induced by B06 "accination.(MC "nfect %is.
San !4 !##=